Home › Companies › Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc. proxy voting records

How asset managers voted at Adverum Biotechnologies, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number00773U
• SEC CIK1501756

Recent shareholder votes

• June 17, 2025 annual meeting (2024-2025 proxy season): 7 items in Adverum Biotechnologies, Inc.'s official results (Form 8-K, filed June 18, 2025); lowest support 75% of votes cast (Approval of the Amendment of Certain Outstanding Stock Options…). Full results and how funds voted.
• June 17, 2024 annual meeting (2023-2024 proxy season): 6 items in Adverum Biotechnologies, Inc.'s official results (Form 8-K, filed June 18, 2024); lowest support 80% of votes cast (. Approval of Adverum Biotechnologies, Inc. 2024 Equity…). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name ADVERUM BIOTECHNOLOGIES INC., as its holders filed it.

Explore Adverum Biotechnologies, Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.